Articles with public access mandates - Gunnar FolprechtLearn more
Not available anywhere: 3
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers
P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ...
Cancer discovery 11 (11), 2780-2795, 2021
Mandates: Helmholtz Association
Validating comprehensive next-generation sequencing results for precision oncology: the NCT/DKTK molecularly aided stratification for tumor eradication research experience
A Lier, R Penzel, C Heining, P Horak, M Fröhlich, S Uhrig, J Budczies, ...
JCO Precision Oncology 2, 1-13, 2018
Mandates: Helmholtz Association
The CIRCULATE trial: circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation (AIO-KRK-0217)
G Folprecht, A Reinacher-Schick, J Weitz, C Lugnier, AL Kraeft, S Wisser, ...
Clinical Colorectal Cancer 21 (2), 170-174, 2022
Mandates: Federal Ministry of Education and Research, Germany
Available somewhere: 27
Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial
T Ruers, F Van Coevorden, CJA Punt, JPEN Pierie, I Borel-Rinkes, ...
JNCI: Journal of the National Cancer Institute 109 (9), djx015, 2017
Mandates: US National Institutes of Health, Cancer Research UK, Dutch Cancer Society
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
J Taieb, K Le Malicot, Q Shi, F Penault-Llorca, O Bouché, J Tabernero, ...
Journal of the National Cancer Institute 109 (5), djw272, 2017
Mandates: US National Institutes of Health
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised …
CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ...
The Lancet Oncology 20 (3), 420-435, 2019
Mandates: German Research Foundation
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy
MI Koukourakis, A Giatromanolaki, E Sivridis, KC Gatter, T Trarbach, ...
Clinical Cancer Research 17 (14), 4892-4900, 2011
Mandates: Cancer Research UK
Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy: a pooled analysis from 2 randomized clinical trials
A Zaanan, Q Shi, J Taieb, SR Alberts, JP Meyers, TC Smyrk, C Julie, ...
JAMA oncology 4 (3), 379-383, 2018
Mandates: US National Institutes of Health
Diagnosis of and therapy for hepatocellular carcinoma
TF Greten, NP Malek, S Schmidt, J Arends, P Bartenstein, W Bechstein, ...
Zeitschrift fur Gastroenterologie 51 (11), 1269, 2013
Mandates: US National Institutes of Health
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer
S Mamlouk, LH Childs, D Aust, D Heim, F Melching, C Oliveira, T Wolf, ...
Nature communications 8 (1), 14093, 2017
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the …
MP Lutz, JR Zalcberg, R Glynne-Jones, T Ruers, M Ducreux, D Arnold, ...
European journal of cancer 63, 11-24, 2016
Mandates: National Institute for Health Research, UK
Dihydropyrimidine dehydrogenase testing prior to treatment with 5-fluorouracil, capecitabine, and tegafur: a consensus paper
B Wörmann, C Bokemeyer, T Burmeister, CH Köhne, M Schwab, D Arnold, ...
Oncology research and treatment 43 (11), 628-636, 2020
Mandates: German Research Foundation
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
S Pant, M Schuler, G Iyer, O Witt, T Doi, S Qin, J Tabernero, DA Reardon, ...
The Lancet Oncology 24 (8), 925-935, 2023
Mandates: US National Institutes of Health
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ...
Journal of Clinical Oncology 41 (11), 2007-2019, 2023
Mandates: US National Institutes of Health, Cancer Research UK
An optimized targeted next-generation sequencing approach for sensitive detection of single nucleotide variants
S Stasik, C Schuster, C Ortlepp, U Platzbecker, M Bornhäuser, J Schetelig, ...
Biomolecular Detection and Quantification 15, 6-12, 2018
Mandates: Federal Ministry of Education and Research, Germany
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ...
Annals of Oncology 33 (11), 1186-1199, 2022
Mandates: Helmholtz Association
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase …
RD Hofheinz, D Arnold, E Fokas, M Kaufmann, T Hothorn, G Folprecht, ...
Annals of Oncology 29 (8), 1793-1799, 2018
Mandates: US Department of Defense
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity
L Möhrmann, M Werner, M Oleś, A Mock, S Uhrig, A Jahn, S Kreutzfeldt, ...
Nature Communications 13 (1), 4485, 2022
Mandates: German Research Foundation, Helmholtz Association
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
A Hennig, F Baenke, A Klimova, S Drukewitz, B Jahnke, S Brückmann, ...
The Journal of pathology 257 (5), 607-619, 2022
Mandates: German Research Foundation
Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials
FA Sinicrope, S Chakrabarti, P Laurent-Puig, L Huebner, TC Smyrk, ...
European Journal of Cancer 144, 101-112, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program